Proactive Care Coordination for Cancer Survivors Who Smoke
Using Cancer Registry Data to Promote Proactive Tobacco Cessation Among Adult Cancer Survivors U48
1 other identifier
interventional
581
1 country
1
Brief Summary
This is a population-based randomized controlled trial of 600 patients with a diagnosis of cancer in the past 2 years and registry indicating smoking at the time of diagnosis, that will inform critical questions regarding the relative efficacy of care coordination options, the reliability of Electronic Health Record (EHR) tobacco use data, and how patients will react to proactive tobacco related communications. Investigators will compare the reach and efficacy of two proactive approaches to enrolling cancer survivors in tobacco treatment (Arm 1: mailed care coordination vs. Arm 2: telephone care coordination) using a two-arm randomized design at two urban cancer centers, and will explore cancer survivor attitudes and preferences about proactive tobacco treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable cancer
Started Mar 2016
Typical duration for not_applicable cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2016
CompletedFirst Submitted
Initial submission to the registry
March 24, 2016
CompletedFirst Posted
Study publicly available on registry
March 30, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 29, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
September 29, 2018
CompletedDecember 11, 2018
December 1, 2018
2.6 years
March 24, 2016
December 7, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Proportion of patients in the study's original proactive outreach cohort of N=600 who complete at least one call with the Quitline
12 Months
Secondary Outcomes (1)
biochemically validated 7-day abstinence
6 Months, 12 Months
Study Arms (2)
Proactive mailed care coordination
ACTIVE COMPARATORProactive telephone care coordination.
ACTIVE COMPARATORInterventions
Care coordinator will make an online referral to the NYS Quitline.
Care coordinator will obtain verbal consent to transfer the patient to the NYS Quitline via 3-way call (warm transfer). The care coordinator will also assist the patient in obtaining NRT from a regular care provider, then call the patient every three months for 12 months to assess current smoking and offer to help smokers obtain additional cessation counseling and medications.
Eligibility Criteria
You may qualify if:
- ICD 9 cancer diagnosis seen at each site in the past two years
- Documentation of current smoking in the cancer registry.
You may not qualify if:
- Dementia
- Stage IV or Stage IIIB cancer
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
New York University School of Medicine
New York, New York, 10016, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Paul Krebs, MD
New York University Medical School
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 24, 2016
First Posted
March 30, 2016
Study Start
March 1, 2016
Primary Completion
September 29, 2018
Study Completion
September 29, 2018
Last Updated
December 11, 2018
Record last verified: 2018-12